14.08.2016 • NewsElaine BurridgeflavorsNigeria

Firmenich Adds Flavors Facility in Nigeria

Switzerland’s Firmenich has opened a flavors facility in Lagos, Nigeria, to boost its product development in the region. The center, which includes laboratories for sweet goods, beverages and savories, will focus on health and nutrition, unique blends reflecting local preferences and competitively priced flavors for all segments of the food industry.

The flavors and fragrances company said Nigeria will serve as a critical hub as it accelerates its innovation efforts to meet customers’ needs across the 30 countries in Sub-Saharan Africa. Firmenich’s CEO Gilbert Ghostine said the significant investment reflected the strategic importance of Sub-Saharan Africa with its population of 800 million and strong growth potential.

“By increasing our proximity to Nigerian consumers, we will focus on creating flavors that appeal to the rich and diverse culture of Nigeria and its neighbouring countries. For instance, we look forward to expanding our industry-leading seafood flavor range and exploring other iconic tonalities,” explained Oddvar Bjorge, Firmenich’s vice president flavors, Sub-Saharan Africa.

The Geneva-headquartered company said it will build on its existing partnership with Nigeria’s Yaba Institute of Technology to drive solutions adapted to the local market.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
06.03.2025 • News

CordenPharma Expands Peptide Manufacturing Platform in Switzerland

Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.